• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中的神经退行性变涉及多种致病机制。

Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms.

作者信息

Levin Michael C, Douglas Joshua N, Meyers Lindsay, Lee Sangmin, Shin Yoojin, Gardner Lidia A

机构信息

Veterans Administration Medical Center.

Department of Neuroscience, University of Tennessee Health Science Center, Memphis, TN, USA.

出版信息

Degener Neurol Neuromuscul Dis. 2014 Mar 12;4:49-63. doi: 10.2147/DNND.S54391. eCollection 2014.

DOI:10.2147/DNND.S54391
PMID:32669900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7337253/
Abstract

Multiple sclerosis (MS) is a complex autoimmune disease that impairs the central nervous system (CNS). The neurological disability and clinical course of the disease is highly variable and unpredictable from one patient to another. The cause of MS is still unknown, but it is thought to occur in genetically susceptible individuals who develop disease due to a nongenetic trigger, such as altered metabolism, a virus, or other environmental factors. MS patients develop progressive, irreversible, neurological disability associated with neuronal and axonal damage, collectively known as neurodegeneration. Neurodegeneration was traditionally considered as a secondary phenomenon to inflammation and demyelination. However, recent data indicate that neurodegeneration develops along with inflammation and demyelination. Thus, MS is increasingly recognized as a neurodegenerative disease triggered by an inflammatory attack of the CNS. While both inflammation and demyelination are well described and understood cellular processes, neurodegeneration might be defined by a diverse pool of any of the following: neuronal cell death, apoptosis, necrosis, and virtual hypoxia. In this review, we present multiple theories and supporting evidence that identify common biological processes that contribute to neurodegeneration in MS.

摘要

多发性硬化症(MS)是一种损害中枢神经系统(CNS)的复杂自身免疫性疾病。该疾病的神经功能障碍和临床病程在不同患者之间差异很大且难以预测。MS的病因仍不明确,但一般认为它发生在具有遗传易感性的个体中,这些个体由于非遗传触发因素,如代谢改变、病毒或其他环境因素而发病。MS患者会出现与神经元和轴突损伤相关的进行性、不可逆的神经功能障碍,统称为神经退行性变。传统上,神经退行性变被认为是炎症和脱髓鞘的继发现象。然而,最近的数据表明,神经退行性变与炎症和脱髓鞘同时发生。因此,MS越来越被认为是一种由中枢神经系统炎症攻击引发的神经退行性疾病。虽然炎症和脱髓鞘是已被充分描述和理解的细胞过程,但神经退行性变可能由以下多种情况定义:神经元细胞死亡、凋亡、坏死和虚拟缺氧。在本综述中,我们提出了多种理论及支持证据,以确定导致MS神经退行性变的常见生物学过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/52aa8fe3d096/DNND-4-49-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/b110564911a5/DNND-4-49-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/b3a59e0deac0/DNND-4-49-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/45913ec2c997/DNND-4-49-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/52aa8fe3d096/DNND-4-49-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/b110564911a5/DNND-4-49-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/b3a59e0deac0/DNND-4-49-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/45913ec2c997/DNND-4-49-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bf/7337253/52aa8fe3d096/DNND-4-49-g0004.jpg

相似文献

1
Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms.多发性硬化症中的神经退行性变涉及多种致病机制。
Degener Neurol Neuromuscul Dis. 2014 Mar 12;4:49-63. doi: 10.2147/DNND.S54391. eCollection 2014.
2
Neuronal injury in chronic CNS inflammation.慢性中枢神经系统炎症中的神经元损伤。
Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29.
3
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond.多发性硬化症的体内和体外实验模型:实验性自身免疫性脑脊髓炎及其他。
Mult Scler Relat Disord. 2012 Jan;1(1):15-28. doi: 10.1016/j.msard.2011.09.002. Epub 2011 Sep 16.
4
Neurodegeneration in autoimmune CNS inflammation.自身免疫性中枢神经系统炎症中的神经退行性变。
Exp Neurol. 2010 Sep;225(1):9-17. doi: 10.1016/j.expneurol.2009.11.019. Epub 2009 Dec 1.
5
B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.进展性多发性硬化症中的 B 细胞和抗体:对神经退行性变和进展的贡献。
Autoimmun Rev. 2016 Sep;15(9):896-9. doi: 10.1016/j.autrev.2016.07.008. Epub 2016 Jul 7.
6
Mitochondrial Dysfunction and Multiple Sclerosis.线粒体功能障碍与多发性硬化症
Biology (Basel). 2019 May 11;8(2):37. doi: 10.3390/biology8020037.
7
Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.脂质过氧化诱导的氧化应激与多发性硬化症中的脱髓鞘炎症和神经退行性变相关。
Eur Neurol. 2014;72(3-4):249-54. doi: 10.1159/000363515.
8
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.进展性多发性硬化症的脑脊液可诱导小鼠发生炎症性脱髓鞘、轴突丢失和星形胶质细胞增生。
Exp Neurol. 2014 Nov;261:620-32. doi: 10.1016/j.expneurol.2014.07.020. Epub 2014 Aug 8.
9
The good and the bad of neuroinflammation in multiple sclerosis.多发性硬化症中神经炎症的利弊
Handb Clin Neurol. 2014;122:59-87. doi: 10.1016/B978-0-444-52001-2.00003-0.
10
MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.磁共振成像证据表明多发性硬化是一种中枢神经系统的弥漫性疾病。
J Neurol. 2005 Nov;252 Suppl 5:v16-24. doi: 10.1007/s00415-005-5004-5.

引用本文的文献

1
Correlation of Neurodegenerative Biomarkers and Functional Outcome in Patients with Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症患者神经退行性生物标志物与功能转归的相关性
Neurol Int. 2025 Aug 7;17(8):123. doi: 10.3390/neurolint17080123.
2
Bowel Dysfunctions in Young Adults with Multiple Sclerosis: A Retrospective Study.多发性硬化症青年成人的肠道功能障碍:一项回顾性研究。
Med Sci (Basel). 2025 Aug 11;13(3):123. doi: 10.3390/medsci13030123.
3
Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis.

本文引用的文献

1
Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.针对非髓鞘抗原的自身抗体在多发性硬化症发病机制中的作用
J Clin Cell Immunol. 2013 Jun 30;4. doi: 10.4172/2155-9899.1000148.
2
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.脂质谱与干扰素-β治疗后首次脱髓鞘事件后 24 个月内患者的病变形成有关。
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1186-91. doi: 10.1136/jnnp-2012-304740. Epub 2013 Apr 17.
3
HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway.
视网膜光学相干断层扫描纵向测量作为多发性硬化症的预后生物标志物:系统评价和荟萃分析
Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200416. doi: 10.1212/NXI.0000000000200416. Epub 2025 May 27.
4
From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases.从肠道到大脑:揭示连接炎症性肠病和神经退行性疾病的潜在血清生物标志物。
Int J Mol Sci. 2024 May 23;25(11):5676. doi: 10.3390/ijms25115676.
5
The Therapeutic Potential of and and Advances in Nutraceutical Delivery Systems in Neurodegenerative Diseases.[具体物质名称]和[具体物质名称]的治疗潜力以及神经退行性疾病中营养保健品递送系统的进展。 (你提供的原文中“and”前后内容缺失,请补充完整以便准确翻译)
Pharmaceuticals (Basel). 2024 May 20;17(5):660. doi: 10.3390/ph17050660.
6
RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis.RNA结合蛋白作为肌萎缩侧索硬化症和多发性硬化症中神经退行性变和炎症的共同基础。
Front Mol Neurosci. 2023 Jul 4;16:1193636. doi: 10.3389/fnmol.2023.1193636. eCollection 2023.
7
Identification of Key Genes and Regulatory Pathways in Multiple Sclerosis Brain Samples: A Meta-Analysis of Micro-Array Datasets.多发性硬化症脑组织样本中关键基因和调控途径的鉴定:基因芯片数据集的荟萃分析。
Int J Mol Sci. 2023 May 27;24(11):9361. doi: 10.3390/ijms24119361.
8
Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis.从复发缓解型到进展型多发性硬化症早期转变生物标志物的最新研究进展。
Int J Mol Sci. 2023 Feb 22;24(5):4375. doi: 10.3390/ijms24054375.
9
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges.基于外泌体的神经退行性疾病纳米医学:当前见解与未来挑战
Pharmaceutics. 2023 Jan 16;15(1):298. doi: 10.3390/pharmaceutics15010298.
10
High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve.高剂量生物素既不能促进再生神经中的髓鞘再生,也不能刺激丙二酰辅酶A的合成。
Neural Regen Res. 2023 Jul;18(7):1623-1624. doi: 10.4103/1673-5374.361542.
羟甲基戊二酰辅酶 A 还原酶抑制剂通过抑制甲羟戊酸途径促进活性氧生成和调节 Akt、Erk 和 p38 信号来诱导淋巴瘤细胞凋亡。
Cell Death Dis. 2013 Feb 28;4(2):e518. doi: 10.1038/cddis.2013.44.
4
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.LC-MS/MS 鉴定人血浆中的一碳循环代谢物。
Electrophoresis. 2013 Jun;34(11):1710-6. doi: 10.1002/elps.201200536. Epub 2013 Apr 23.
5
RNA-binding proteins in Mendelian disease.孟德尔疾病中的 RNA 结合蛋白。
Trends Genet. 2013 May;29(5):318-27. doi: 10.1016/j.tig.2013.01.004. Epub 2013 Feb 15.
6
Antibody transfection into neurons as a tool to study disease pathogenesis.将抗体转染到神经元中作为研究疾病发病机制的一种工具。
J Vis Exp. 2012 Sep 26(67):4154. doi: 10.3791/4154.
7
RNA-binding proteins in neurological disease.神经疾病中的RNA结合蛋白
Brain Res. 2012 Jun 26;1462:1-2. doi: 10.1016/j.brainres.2012.05.038.
8
Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation.鉴定髓鞘中具有缓解神经炎症作用的天然脂肪酸。
Sci Transl Med. 2012 Jun 6;4(137):137ra73. doi: 10.1126/scitranslmed.3003831.
9
Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice.阿尔茨海默病中胆碱能相关的 hnRNP-A/B 丢失会损害小鼠大脑皮层的剪接并影响认知功能。
EMBO Mol Med. 2012 Aug;4(8):730-42. doi: 10.1002/emmm.201100995. Epub 2012 May 25.
10
The updated biology of hypoxia-inducible factor.缺氧诱导因子的更新生物学。
EMBO J. 2012 May 30;31(11):2448-60. doi: 10.1038/emboj.2012.125. Epub 2012 May 4.